Life,
Год журнала:
2023,
Номер
13(3), С. 617 - 617
Опубликована: Фев. 23, 2023
The
outbreak
of
coronavirus
disease
2019
(COVID-19)
caused
by
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
had
a
profound
impact
on
the
world’s
health
and
economy.
Although
end
pandemic
may
come
in
2023,
it
is
generally
believed
that
virus
will
not
be
completely
eradicated.
Most
likely,
become
an
endemicity.
rapid
development
vaccines
different
types
(mRNA,
subunit
protein,
inactivated
virus,
etc.)
some
other
antiviral
drugs
(Remdesivir,
Olumiant,
Paxlovid,
has
provided
effectiveness
reducing
COVID-19’s
worldwide.
However,
circulating
SARS-CoV-2
been
constantly
mutating
with
emergence
multiple
variants,
which
makes
control
COVID-19
difficult.
There
still
pressing
need
for
developing
more
effective
to
fight
against
disease.
Plants
have
promising
production
platform
both
bioactive
chemical
compounds
(small
molecules)
recombinant
therapeutics
(big
molecules).
naturally
produce
diverse
range
as
secondary
metabolites,
such
alkaloids,
terpenoids/terpenes
polyphenols,
are
rich
source
countless
compounds.
can
also
genetically
engineered
valuable
therapeutics.
This
molecular
farming
plants
unprecedented
opportunity
vaccines,
antibodies,
biologics
diseases
because
its
potential
advantages,
low
cost,
safety,
high
volume.
review
summarizes
latest
advancements
plant-derived
used
combat
discusses
prospects
challenges
plant-based
agents.
Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Май 30, 2024
Introduction
In
recent
years,
diverse
initiatives
have
been
carried
out
to
control
the
COVID-19
pandemic,
ranging
from
measures
restricting
social
activities
analyzing
drugs
and
vaccines.
Studies
on
herbal
medicines
are
also
increasingly
conducted
in
various
countries
as
an
adjuvant
therapy
or
supplement.
Therefore,
this
systematic
review
aimed
investigate
efficacy
of
analyzed
through
clinical
trials
with
randomized
controlled
trial
method.
The
outcomes
Length
Stay
(LOS),
Negative
Conversion
Time
(NCT),
Rate
(NCR)
were
main
focus.
Methods
An
extensive
literature
spanning
2019
2023
was
using
well-known
databases
including
PubMed,
Scopus,
Cochrane.
search
included
relevant
keywords
such
“randomized
trial,”
“COVID-19,”
“herbal
medicine.”
Results
A
total
8
articles
part
inclusion
criteria
LOS,
NCT,
NCR.
terms
LOS
outcomes,
all
types
showed
significant
results,
Persian
Medicine
Herbal
(PM
Herbal),
Barley
Water
(PBW),
Jingyin
Granules
(JY
granules),
Reduning
Injection,
Phyllanthus
emblica
(Amla).
However,
only
JY
granules
results
NCR
outcome,
while
Injection
reducing
NCT.
Conclusion
These
findings
enrich
our
understanding
potential
benefits
influencing
NCT
parameters
patients.
worked
treat
antiviral,
anti-inflammatory,
immunomodulatory
mechanisms.
Journal of Cellular and Molecular Medicine,
Год журнала:
2025,
Номер
29(5)
Опубликована: Март 1, 2025
Alzheimer's
disease
(AD)
is
a
neurodegenerative
caused
by
the
progressive
deposition
of
extracellular
amyloid
beta
(Aβ)
and
intracellular
neurofibrillary
tangles
(NFTs).
Of
note,
metabolic
disorders
such
as
insulin
resistance
(IR)
type
2
diabetes
(T2D)
are
associated
with
development
brain
IR
neurodegeneration.
In
addition,
AD
neuropathology
linked
cognitive
impairment
accelerate
peripheral
progression
T2D.
Therefore,
there
bidirectional
relationship
between
T2D
AD.
It
has
been
demonstrated
that
induce
dysregulation
peroxisome
proliferator-activated
receptor
alpha
(PPAR-α)
leading
to
central
disturbances.
Hence,
dysregulated
PPAR-α
could
be
shared
mechanism
in
both
T2D,
restoration
signalling
agonist
fenofibrate
(FN)
may
alleviate
this
review
aims
shed
light
on
potential
involvement
AD,
how
FN
effective
management
seems
dual
neuroprotective
antidiabetic
effects
can
mitigate
T2D-related
complications
modulating
various
cellular
processes
inflammatory
pathways.
conclusion,
possible
candidate
different
pathways
involved
pathogenesis
these
conditions.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(6), С. 2550 - 2550
Опубликована: Март 12, 2025
Even
though
in
mid-2023
the
World
Health
Organization
declared
end
of
public
health
emergency
international
concern
status
for
COVID-19,
many
areas
uncertainty
about
SARS-CoV-2
infection
pathophysiology
remain.
Although
last
4
years
pharmaceutical
industries
widely
invested
development
effective
antiviral
treatments
and
vaccines,
large
disparities
their
availability
worldwide
still
exist,
thus
fostering
investigation
nutritional
supplements
as
adjuvant
therapeutic
approaches
disease
management,
especially
resource-limited
settings.
During
COVID-19
pandemic,
vitamin
D
has
been
used
an
over-the-counter
solution
to
improve
evolution,
thanks
its
known
immunomodulatory
anti-inflammatory
actions.
Ecological
observational
studies
support
a
relationship
between
hypovitaminosis
negative
outcomes
and,
according
this
evidence,
several
research
groups
investigated
role
supplementation
protecting
from
and/or
improving
evolution.
This
narrative
review
is
intended
offer
insights
into
existing
data
on
D’s
biological
effects
respiratory
infections,
COVID-19.
Furthermore,
it
will
also
brief
overview
complex
interplay
vaccine-elicited
immune
response,
with
special
attention
anti-COVID-19
vaccines.